India  
 
NewsR.in

Coronavirus vaccine trials still struggling for diversity

Video Credit: NBC 26 Wisconsin - Duration: 02:44s - Published
Coronavirus vaccine trials still struggling for diversity

Coronavirus vaccine trials still struggling for diversity

Right now, nine COVID-19 vaccines are in or near a large-scale human trial phase.

But enrollment of minorities in the trials remains a challenge.


You Might Like

Related news from verified sources

Oxford’s vaccine AstraZeneca trial resumes in UK

Drugs giant AstraZeneca on Saturday said it had resumed a Covid-19 vaccine trial after getting the...
IndiaTimes - Published

AstraZeneca halts coronavirus vaccine trial after volunteer develops ‘unexpected’ illness

In a significant development, pharmaceutical company AstraZeneca on Tuesday (September 8) said that...
Zee News - Published

'Covaxin': Bharat Biotech's COVID-19 vaccine completes Phase-I trials at PGI Rohtak; here's when it will hit markets

The first phase of the clinical trials for Bharat Biotech's coronavirus disease (COVID-19) vaccine...
DNA - Published


Related videos from verified sources

New promising results from Moderna vaccine trial [Video]

New promising results from Moderna vaccine trial

Some promising news coming from the Moderna vaccine trial. Researchers say it appears to create a strong immune response in older people, as well as younger adults.

Credit: KTNV Channel 13 Las Vegas     Duration: 00:21Published
Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister [Video]

Covid vaccine: Covaxin phase 3 trials on 3,000 people in UP, says minister

Hyderabad-based pharma company Bharat Biotech to conduct phase 3 clinical trial tests in October. Uttar Pradesh Health Minister Jai Pratap Singh said around 3,000 people to be tested under the phase 3..

Credit: HT Digital Content     Duration: 02:29Published
Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials [Video]

Moderna and Regeneron Jump on Positive Covid-19 Vaccine Trials

Biopharmaceutical giants Moderna and Regeneron lead other biotech companies higher after they each announce positive Covid-19 vaccine trial results.

Credit: The Street     Duration: 02:37Published